Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management
PS Nyasulu, CO Doumbia, V Ngah… - Current Opinion in …, 2024 - journals.lww.com
To effectively manage MDR-TB and its co-morbidity with HIV/AIDS, proactive screening
programs are imperative. The review highlights the necessity of active follow-up strategies to …
programs are imperative. The review highlights the necessity of active follow-up strategies to …
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing …
A Vīksna, D Sadovska, I Berge, I Bogdanova… - BMC Infectious …, 2023 - Springer
Background Multidrug-resistant tuberculosis (MDR–TB) remains a major public health
problem in many high tuberculosis (TB) burden countries. Phenotypic drug susceptibility …
problem in many high tuberculosis (TB) burden countries. Phenotypic drug susceptibility …
Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China
E Tong, Y Zhou, Z Liu, Y Zhu, M Zhang… - Infection and Drug …, 2023 - Taylor & Francis
Purpose This study aimed to determine the prevalence and molecular characterization of
bedaquiline (BDQ) resistance among rifampicin-resistant tuberculosis (RR-TB) isolates …
bedaquiline (BDQ) resistance among rifampicin-resistant tuberculosis (RR-TB) isolates …
Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis
Clofazimine (CFZ) and bedaquiline (BDQ) are currently used for the treatment of multidrug-
resistant (MDR) Mycobacterium tuberculosis (Mtb) strains. In recent years, adding CFZ and …
resistant (MDR) Mycobacterium tuberculosis (Mtb) strains. In recent years, adding CFZ and …
HIV co-infection is associated with reduced Mycobacterium tuberculosis transmissibility in sub-Saharan Africa
Persons living with HIV are known to be at increased risk of developing tuberculosis (TB)
disease upon infection with Mycobacterium tuberculosis (Mtb). However, it has remained …
disease upon infection with Mycobacterium tuberculosis (Mtb). However, it has remained …
Genomic, phenotypic and demographic characterization of Mycobacterium tuberculosis in Israel in 2021
Y Losev, M Rubinstein, I Nissan, P Haviv… - Frontiers in Cellular …, 2023 - frontiersin.org
According to World Health Organization WHO, Tuberculosis (TB) is the second cause of
death from infectious disease worldwide. During 2021, 10.6 million people were infected …
death from infectious disease worldwide. During 2021, 10.6 million people were infected …
Mycobacterium tuberculosis Lineage Distribution Using Whole‐Genome Sequencing and Bedaquiline, Clofazimine, and Linezolid Phenotypic Profiles among …
Tuberculosis (TB) is caused by Mycobacterium tuberculosis infection. Indonesia is ranked
second in the world for TB cases. New anti‐TB drugs from groups A and B, such as …
second in the world for TB cases. New anti‐TB drugs from groups A and B, such as …
[HTML][HTML] African Centers of Excellence in Bioinformatics and Data Intensive Science: Building Capacity for Enhancing Data Intensive Infectious Diseases Research in …
MY Giovanni, C Whalen, DE Hurt… - Journal of infectious …, 2023 - ncbi.nlm.nih.gov
Africa faces both a disproportionate burden of infectious diseases coupled with unmet needs
in bioinformatics and data science capabilities which impacts the ability of African …
in bioinformatics and data science capabilities which impacts the ability of African …
[HTML][HTML] Acquired bedaquiline and fluoroquinolones resistance during treatment follow-up in Oromia Region, North Shewa, Ethiopia
G Diriba, A Alemu, BZ Ayano, B Yenew, M Hailu… - IDCases, 2024 - Elsevier
Background Bedaquiline (BDQ) is an effective drug currently used for multidrug-resistant or
rifampicin-resistant TB (MDR/RR-TB) and pre-extensively drug-resistant TB (pre-XDR-TB) …
rifampicin-resistant TB (MDR/RR-TB) and pre-extensively drug-resistant TB (pre-XDR-TB) …
Генетические аспекты лекарственной устойчивости микобактерий туберкулеза к новым препаратам с противотуберкулезной активностью
АВ Кукурика, ЕИ Веселова… - Туберкулез и болезни …, 2023 - tibl-journal.com
Аннотация Проанализированы 57 публикаций, посвященных изучению генетических
механизмов формирования лекарственной устойчивости микобактерий туберкулеза к …
механизмов формирования лекарственной устойчивости микобактерий туберкулеза к …